When you’re pregnant, your blood contains fragments of your baby’s DNA. A non-invasive prenatal test (NIPT) is a new type of screening test that analyses this circulating DNA in a sample of your blood to predict the risk of your baby having selected genetic abnormalities. Collecting your blood sample for NIPT poses no threat to your baby. It is possible from week 10 of your pregnancy.

inqaba biotec offers CentoNIPT® for singleton and twin pregnancies test:

This test option screens for the presence of Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), Sex chromosome aneuploidies and gender determination of the baby on request.

Test currently available in Gauteng and Cape Town (at our premises).

For more information and/or to order a kit, please contact us on:

Genetic counselling support is available on request for patients with positive or negative test results.